相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Early re-staging and molecular subtype shift surveillance of locally recurrent or metastatic breast cancer: A new PET/CT integrated precise algorithm
Wei Guo et al.
CANCER LETTERS (2018)
Breast Cancer Screening and Diagnosis, Version 3.2018
Therese B. Bevers et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy
Jennifer A. Crozier et al.
CLINICAL BREAST CANCER (2016)
Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis
Rainer J. Klement et al.
PLOS ONE (2016)
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Amylou C. Dueck et al.
JAMA ONCOLOGY (2015)
Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model
Raphael Johannes Morscher et al.
PLOS ONE (2015)
Effects of low-carbohydrate, high-fat diets on apparent digestibility of minerals and trace elements in rats
Lena Frommelt et al.
NUTRITION (2014)
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
An-Wen Chan et al.
ANNALS OF INTERNAL MEDICINE (2013)
Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study
Ahmad Awada et al.
LANCET ONCOLOGY (2013)
The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic Cancer
Angela M. Poff et al.
PLOS ONE (2013)
The Prevention and Treatment of Missing Data in Clinical Trials
Roderick J. Little et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
WJ Gradishar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Extending survival with chemotherapy in metastatic breast cancer
J O'Shaughnessy
ONCOLOGIST (2005)
Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both
EA Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Testing psychometric properties of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30)
H Zhao et al.
JOURNAL OF EPIDEMIOLOGY (2004)
Clinical effect of irinotecan in advanced and metastatic breast cancer patients previously treated with doxorubicin- and docetaxel-containing regimens
Y Shigeoka et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
